Specification

लाइफ स्पैन
24 months from manufacturing date

संकेत
Acromegaly, neuroendocrine tumors, symptoms associated with carcinoid tumors

नमक की संरचना
Octreotide Acetate 20 mg (or 30 mg) per vial

मेडिसिन की उत्पत्ति
India

पैकेजिंग का प्रकार
Vial with carton

खुराक प्रपत्र
Long-Acting Injectable Suspension

ब्रांड का नाम
Octreotide LAR

पैकेजिंग (मात्रा प्रति बॉक्स)
1 Vial per box

दवा का प्रकार

सामग्रियां
Octreotide Acetate

भौतिक रूप

फंक्शन

के लिए सुझाया गया
Adults

खुराक
As prescribed by physician

खुराक संबंधी दिशा-निर्देश
Administered via intramuscular injection, usually every 4 weeks

के लिए उपयुक्त

क्वांटिटी
1 x 10 ml vial

स्टोरेज निर्देश
Store below 25C, protect from light

Prescription/Non Prescription
Prescription

Administration Route
Intramuscular

Therapeutic Class
Hormone Analog

Appearance
Sterile powder in vial with separate diluent

Shelf Life After Opening
Use immediately after reconstitution

Storage Condition
Do not freeze; keep in original package

Reconstitution
Requires reconstitution with provided diluent prior to use

Trade Information

Minimum Order Quantity
1 टुकड़ा

आपूर्ति की क्षमता
प्रति दिन

डिलीवरी का समय
हफ़्ता

About

Octreotide LAR Injection exemplifies top-notch pharmaceutical engineering, serving as a paragon in hormone analog treatment. This gorgeous formulation features Octreotide Acetate, expertly presented as a sterile powder for reconstitution, with a competitive pricing advantage for a limited time. Designed for intramuscular administration, it is suitable for adults and the elderly with acromegaly, neuroendocrine tumors, and symptomatic carcinoid tumors. With a special emphasis on therapeutic excellence and safety, Octreotide LAR ensures high efficacy, exceptional purity, and trusted results from an Indian exporter, supplier, and wholesaler.

Specialized Therapeutic Solution for Targeted Hormone Management

Octreotide LAR Injection is specifically indicated for the management of acromegaly, neuroendocrine tumors, and carcinoid syndrome-related symptoms. It is designed for general use in adults and elderly patients requiring antineoplastic and endocrine therapy. Its features include long-acting, precise dosing as prescribed, and administration via intramuscular injection every four weeks. Suitable for hospital, oncology centers, or outpatient clinics, this injection is supplied in a sterile vial with a separate diluent for immediate use after reconstitution.

Certifications, Export Options, and Payment Terms Offered

Octreotide LAR Injection is manufactured according to stringent pharmaceutical certifications, ensuring both safety and efficacy for global export markets. The product is shipped from major FOB ports in India, allowing flexibility and convenience for importers. We offer favorable payment terms, designed to meet the needs of exporters, traders, and wholesalers. With reliable supply and competitive charges, Octreotide LAR Injection is a preferred option for businesses seeking quality hormone analog therapies worldwide.

FAQ's of Octreotide LAR Injection:

Q: How should Octreotide LAR Injection be kept after opening and reconstitution?

A: Once reconstituted with the provided diluent, it must be used immediately. Store the prior unused vials below 25C, protected from light, and never freeze the product.

Q: What is the recommended administration process for Octreotide LAR Injection?

A: The injection is administered by healthcare professionals as an intramuscular injection, typically once every four weeks, following the prescribed dosage guidelines from your physician.

Q: When is Octreotide LAR Injection generally prescribed?

A: This medication is recommended for adults and elderly patients diagnosed with acromegaly, neuroendocrine tumors, or those experiencing symptoms related to carcinoid tumors.

Q: Where is Octreotide LAR Injection typically used?

A: It is most commonly used in hospitals, specialty clinics, or oncology centers where medical professionals can oversee the reconstitution and administration process.

Q: What benefits does Octreotide LAR Injection offer patients?

A: Patients benefit from its long-acting, targeted action, providing effective symptom control and treatment for hormone-related conditions with reduced dosing frequency.

Q: Is Octreotide LAR Injection available for export or wholesale?

A: Yes, the injection is available for export, supply, and wholesale from India, meeting the requirements of international markets and regulatory standards.